BCL2 and hypopharyngeal carcinoma: According to Lu et al. [32], in the FaDu/Twist+ hypopharyngeal carcinoma cell line, caspase-3, caspase-9, Bcl-2, and Bax exhibited alterations favoring anti-apoptosis, suggesting that Twist1 expression may promote chemotherapy resistance by suppressing apoptosis.